Combined Nutritional Therapies for the Treatment of Ulcerative Colitis
NCT03444311 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2020-07-08
Summary
Ulcerative colitis (UC) is an entity of complex etiology where environmental, genetic and intestinal microflora-related factors trigger and perpetuate a chronic inflammation of the gastrointestinal tract. It is suspected that an alteration in primary intestinal microbial colonization (dysbiosis) could trigger, or at least contribute to, said oversized immune response. The hypothesis is that the administration of a series of fibers, could improve the bacterial diversity and repair the dysbiosis that has been seen in patients affected by ulcerative colitis, improving the clinical evolution of it. The primary objective of the present study is to know the impact on the microbiota of patients with UC in remission derived from the administration of dietary fibers. The RETOS study is a pilot project in which a population of patients with UC is tested for the effect on the composition of the microbiota that would have the administration of various combinations of fibers, in addition to the tolerability and acceptance by the patient. The clinical applicability derived from this intervention would be to improve the diversity of intestinal flora of patients with ulcerative colitis.
Conditions
- Colitis, Ulcerative
Interventions
- DIETARY_SUPPLEMENT
-
A: 1 dosis
1 dosis (3E+09 cfu/d + 6 g of fiber) Two different combinations of fibers (formula A and B) will be tested with the following administration pattern for both groups. Week 1: Formula A Week 2: Formula A Week 3: Formula B Week 4: Formula B Composition of an envelope of formula A: Formula A Composition (g) Pectin 1 B-glucan oatmeal 0.25 High-grade polymerization inulin 1.75 Inulin of low degree of polymerization 1,5 Polydextrose 1 Guar gum partially hydrolyzed 0,5 TOTAL 6 Composition of an envelope of formula B: Formula B Composition (g) Pectin 1 B-glucan oatmeal 0.25 High-grade polymerization inulin 1 Inulin of low degree of polymerization 0.75 Polydextrose 2.5 Guar gum partially hydrolyzed 0,5 TOTAL 6
- DIETARY_SUPPLEMENT
-
B: 2 dosis
1 dosis (3E+09 cfu/d + 12 g of fiber) Two different combinations of fibers (formula A and B) will be tested with the following administration pattern for both groups. Week 1: Formula A Week 2: Formula A Week 3: Formula B Week 4: Formula B Composition of an envelope of formula A: Formula A Composition (g) Pectin 1 B-glucan oatmeal 0.25 High-grade polymerization inulin 1.75 Inulin of low degree of polymerization 1,5 Polydextrose 1 Guar gum partially hydrolyzed 0,5 TOTAL 6 Composition of an envelope of formula B: Formula B Composition (g) Pectin 1 B-glucan oatmeal 0.25 High-grade polymerization inulin 1 Inulin of low degree of polymerization 0.75 Polydextrose 2.5 Guar gum partially hydrolyzed 0,5 TOTAL 6
Sponsors & Collaborators
-
AB Biotics, SA
lead INDUSTRY
Principal Investigators
-
Ariana Salavert, PhD · Ab-biotics
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-03-08
- Primary Completion
- 2019-07-02
- Completion
- 2020-07-02
Countries
- Spain
Study Locations
More Related Trials
-
Use of the Ulcerative Colitis Diet for Induction of Remission
NCT02217722 ·Status: TERMINATED ·Phase: NA
-
FMT for Remission of Active Ulcerative Colitis in Adults
NCT04202211 ·Status: WITHDRAWN ·Phase: PHASE2
-
Lactobacillus Reuteri ATCC PTA 4659 in Ulcerative Colitis
NCT03798210 ·Status: UNKNOWN ·Phase: PHASE2
-
Effects of Probiotics in Patients With Ulcerative Colitis
NCT00578799 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)
NCT04677179 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy & Safety of TD-1473 in Ulcerative Colitis
NCT03758443 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Fecal Microbiota Transplantation as a Treatment for Ulcerative Colitis
NCT04434872 ·Status: TERMINATED ·Phase: PHASE2
-
Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)
NCT02463305 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis
NCT00152841 ·Status: TERMINATED ·Phase: PHASE2
-
Fecal Microbiota Transplantation in Patients With Ulcerative Colitis
NCT01961492 ·Status: WITHDRAWN ·Phase: NA
-
Fecal Microbiota Transplantation (FMT) in the Management of Active Ulcerative Colitis
NCT02227342 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Ulcerative Colitis on Advanced Therapies
NCT06906445 ·Status: RECRUITING ·Phase: NA
-
Interest of Propionibacterium Freudenreichii for the Treatment of Mild to Moderate Ulcerative Colitis
NCT02488954 ·Status: TERMINATED ·Phase: NA
-
Immunonutrition in Ulcerative Colitis
NCT03594708 ·Status: UNKNOWN ·Phase: NA
-
Impact of Fecal Microbiota Transplantation in Ulcerative Colitis
NCT03483246 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Phase 2 Dose-finding IMU-838 for Ulcerative Colitis
NCT03341962 ·Status: TERMINATED ·Phase: PHASE2
-
Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis
NCT03998488 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Ulcerative Colitis
NCT07080034 ·Status: RECRUITING ·Phase: PHASE2
-
Ulcerative Colitis Relapse Prevention by Prebiotics
NCT02865707 ·Status: COMPLETED ·Phase: NA
-
Eicosapentaenoic Free Fatty Acid and Fecal Calprotectin in Inflammatory Bowel Diseases
NCT02179372 ·Status: COMPLETED ·Phase: NA
-
Fecal Microbiota Transplantation for Ulcerative Colitis
NCT03016780 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colitis
NCT01461317 ·Status: COMPLETED ·Phase: PHASE2
-
Diet Intervention Treatment for Active Ulcerative Colitis
NCT04121806 ·Status: RECRUITING ·Phase: NA
-
Determination of the Optimal Treatment Target in Ulcerative Colitis
NCT04259138 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis
NCT02764229 ·Status: TERMINATED ·Phase: PHASE2